Inhibitor Therapeutics INTI
OTC INTI
$0.08 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibitor Therapeutics (INTI) EV to FCF (2022 - 2023)

Updated

Inhibitor Therapeutics' (INTI) EV to FCF was -0.09 for Q3 2023.

Analysis

Inhibitor Therapeutics (INTI) EV to FCF (2022 - 2023) Analysis & Trends

Over the twelve months ended Sep 30, 2023, Inhibitor Therapeutics' EV to FCF came in at -3.41; for FY2022, it came in at 2.10.

  • Five-year quarterly EV to FCF spans a low of -0.31 in Q2 2023 and a high of 2.10 in Q4 2022.
  • Per Business Quant data, the three quarters before Q3 2023 came in at -0.31 (Q2 2023), -0.04 (Q1 2023) and 2.10 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Inhibitor Therapeutics 13.90 Mn 6.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -0.09
Jun 30, 2023 -0.31
Mar 31, 2023 -0.04
Dec 31, 2022 2.10
API Access

Inhibitor Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=INTI&period=max&api_key=YOUR_API_KEY